Brian C. Evanko, President and Chief Executive Officer of Cigna Group, filed a Form 4 on September 2, 2026, disclosing equity awards granted on September 1, 2026, in his common stock and employee stock option holdings.

Key Highlights

  • Restricted stock award: Evanko acquired 3,113 shares of Common Stock at $0 on September 1, 2026, vesting in three equal annual installments beginning September 1, 2027.
  • Direct ownership after transaction: Evanko directly holds 41,030 shares of Common Stock following the reported transaction.
  • Indirect holdings: Evanko holds 25,614 shares indirectly through a GRAT and 919.5791 shares indirectly through The Cigna Group's 401(k) Plan.
  • Stock option grant: Evanko received an employee stock option to purchase 6,716 shares at an exercise price of $281.1325, granted September 1, 2026, with an expiration date of September 1, 2037.
  • Option vesting schedule: The option vests in three equal annual installments beginning September 1, 2027.
  • Role confirmed: Evanko is identified in the filing as President and Chief Executive Officer of Cigna Group (NYSE:CI).

Cigna Group CEO Evanko's September 2026 Equity Award Details

According to the Form 4 filed with the SEC, Brian C. Evanko, serving as President and Chief Executive Officer of Cigna Group (NYSE:CI), received two equity awards on September 1, 2026. The first was an acquisition of 3,113 restricted shares of Common Stock, $.01 Par Value, at a price of $0, reported under transaction code "A." Per the filing's explanation of responses, these restricted shares vest in three equal annual installments beginning September 1, 2027.

The filing also reports the grant of an Employee Stock Option (Right to Buy) for 6,716 shares of Common Stock, $0.01 Par Value, at a conversion or exercise price of $281.1325 per share. The option was granted on September 1, 2026, becomes exercisable beginning September 1, 2027, in three equal annual installments, and expires on September 1, 2037. The price of the derivative security at grant is reported as $0.

Following these transactions, Evanko directly holds 41,030 shares of Cigna Group Common Stock. The filing further discloses indirect beneficial ownership of 25,614 shares held through a GRAT and 919.5791 shares held through The Cigna Group's 401(k) Plan, the latter described as representing shares "acquired through ongoing participation" in the plan. The Form 4 was signed by Tyler Gratton as attorney-in-fact and filed on September 2, 2026.

What Was Disclosed

Cigna Group CEO Brian C. Evanko disclosed the acquisition of 3,113 restricted shares and an option for 6,716 shares, both granted September 1, 2026, at $0 cost. His total direct beneficial ownership stands at 41,030 shares following the transaction.